| Identification | Back Directory | [Name]
6-Quinazolinamine (9CI) | [CAS]
101421-72-1 | [Synonyms]
6-Quinazolinamine
6-Aminoquinazoline
Quinazolin-6-aMine
Quinazolin-6-ylamine
6-Quinazolinamine (9CI) | [Molecular Formula]
C8H7N3 | [MDL Number]
MFCD10697883 | [MOL File]
101421-72-1.mol | [Molecular Weight]
145.16 |
| Chemical Properties | Back Directory | [Melting point ]
213.5-214 °C (sublm) | [Boiling point ]
335.9±15.0 °C(Predicted) | [density ]
1.292±0.06 g/cm3(Predicted) | [storage temp. ]
2-8°C(protect from light) | [pka]
2.96±0.26(Predicted) |
| Hazard Information | Back Directory | [Uses]
6-Aminoquinazoline has an effect on TRPC1-mediated neuronal store-operated Ca entry pathway, which delayed the progression of Huntington''s disease motor phenotype in Drosophila, making it a therapeutic target for Huntington''s disease treatment. | [Synthesis Reference(s)]
Tetrahedron, 62, p. 12351, 2006 DOI: 10.1016/j.tet.2006.09.103 |
|
|